148 related articles for article (PubMed ID: 36340458)
1. Examination of the Effect of Proton Pump Inhibitors on the Anticancer Activity of Oxaliplatin.
Hashizume J; Sato K; Nakagawa H; Harasawa H; Honda T; Kodama Y
Cancer Diagn Progn; 2022; 2(6):620-626. PubMed ID: 36340458
[TBL] [Abstract][Full Text] [Related]
2. Proton Pump Inhibitors Ameliorate Oxaliplatin-induced Peripheral Neuropathy: Retrospective Analysis of Two Real-world Clinical Databases.
Kobayashi A; Ikemura K; Wakai E; Kondo M; Okuda M
Anticancer Res; 2023 Dec; 43(12):5613-5620. PubMed ID: 38030205
[TBL] [Abstract][Full Text] [Related]
3. Effects of Proton Pump Inhibitors on FOLFOX and CapeOx Regimens in Colorectal Cancer.
Wong GG; Ha V; Chu MP; Dersch-Mills D; Ghosh S; Chambers CR; Sawyer MB
Clin Colorectal Cancer; 2019 Mar; 18(1):72-79. PubMed ID: 30551953
[TBL] [Abstract][Full Text] [Related]
4. Rabeprazole intake does not affect systemic exposure to capecitabine and its metabolites, 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, and 5-fluorouracil.
Sekido M; Fujita KI; Kubota Y; Ishida H; Takahashi T; Ohkuma R; Tsunoda T; Ishikawa F; Shibanuma M; Sasaki Y
Cancer Chemother Pharmacol; 2019 Jun; 83(6):1127-1135. PubMed ID: 30972456
[TBL] [Abstract][Full Text] [Related]
5. Statins enhances antitumor effect of oxaliplatin in KRAS-mutated colorectal cancer cells and inhibits oxaliplatin-induced neuropathy.
Tsubaki M; Takeda T; Matsuda T; Kishimoto K; Takefuji H; Taniwaki Y; Ueda M; Hoshida T; Tanabe K; Nishida S
Cancer Cell Int; 2023 Apr; 23(1):73. PubMed ID: 37069612
[TBL] [Abstract][Full Text] [Related]
6. Perifosine enhances the potential antitumor effect of 5-fluorourasil and oxaliplatin in colon cancer cells harboring the PIK3CA mutation.
Morii Y; Tsubaki M; Takeda T; Otubo R; Seki S; Yamatomo Y; Imano M; Satou T; Shimomura K; Nishida S
Eur J Pharmacol; 2021 May; 898():173957. PubMed ID: 33662352
[TBL] [Abstract][Full Text] [Related]
7. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer.
Giacchetti S; Perpoint B; Zidani R; Le Bail N; Faggiuolo R; Focan C; Chollet P; Llory JF; Letourneau Y; Coudert B; Bertheaut-Cvitkovic F; Larregain-Fournier D; Le Rol A; Walter S; Adam R; Misset JL; Lévi F
J Clin Oncol; 2000 Jan; 18(1):136-47. PubMed ID: 10623704
[TBL] [Abstract][Full Text] [Related]
8. Proton Pump Inhibitors Enhance the Antitumor Effect of Chemotherapy for Esophageal Squamous Cell Carcinoma.
Matsumura S; Ishikawa T; Yoshida J; Morita R; Sakakida T; Endo Y; Doi T; Hirose R; Inoue K; Dohi O; Yoshida N; Uchiyama K; Takagi T; Konishi H; Yasui K; Naito Y; Itoh Y
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626000
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs).
Nies AT; Hofmann U; Resch C; Schaeffeler E; Rius M; Schwab M
PLoS One; 2011; 6(7):e22163. PubMed ID: 21779389
[TBL] [Abstract][Full Text] [Related]
10. The value of oxaliplatin in combination with continuous infusion +/- bolus 5-fluorouracil and levo-folinic acid in metastatic colorectal cancer progressing after 5FU-based chemotherapy: a GISCAD (Italian Group for the Study of Digestive Tract) cancer phase II trial.
Mosconi S; Cascinu S; Zaniboni A; Catalano V; Giordani P; Beretta GD; Martignoni G; Pancera G; Baldelli AM; Poletti P; Curti C; Labianca R
Tumori; 2000; 86(6):465-9. PubMed ID: 11218187
[TBL] [Abstract][Full Text] [Related]
11. A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer.
Lévi F; Misset JL; Brienza S; Adam R; Metzger G; Itzakhi M; Caussanel JP; Kunstlinger F; Lecouturier S; Descorps-Declère A
Cancer; 1992 Feb; 69(4):893-900. PubMed ID: 1735081
[TBL] [Abstract][Full Text] [Related]
12. Oxaliplatin and protracted continuous 5-fluorouracil infusion in patients with pretreated advanced colorectal carcinoma.
Martoni A; Mini E; Pinto C; Nobili S; Gentile AL; Dentico P; Angelelli B; Scicolone S; Piana E; Mazzei T
Ann Oncol; 2001 Apr; 12(4):519-24. PubMed ID: 11398887
[TBL] [Abstract][Full Text] [Related]
13. Proton Pump Inhibitor Use and the Efficacy of Chemotherapy in Metastatic Colorectal Cancer: A Post Hoc Analysis of a Randomized Phase III Trial (AXEPT).
Kim SY; Lee JS; Kang J; Morita S; Park YS; Sakamoto J; Muro K; Xu RH; Kim TW
Oncologist; 2021 Jun; 26(6):e954-e962. PubMed ID: 33644953
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitors increase the chemosensitivity of patients with advanced colorectal cancer.
Wang X; Liu C; Wang J; Fan Y; Wang Z; Wang Y
Oncotarget; 2017 Aug; 8(35):58801-58808. PubMed ID: 28938598
[TBL] [Abstract][Full Text] [Related]
15. Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer: Secondary Analysis of the TRIO-013/LOGiC Randomized Clinical Trial.
Chu MP; Hecht JR; Slamon D; Wainberg ZA; Bang YJ; Hoff PM; Sobrero A; Qin S; Afenjar K; Houe V; King K; Koski S; Mulder K; Hiller JP; Scarfe A; Spratlin J; Huang YJ; Khan-Wasti S; Chua N; Sawyer MB
JAMA Oncol; 2017 Jun; 3(6):767-773. PubMed ID: 27737436
[TBL] [Abstract][Full Text] [Related]
16. Whole-body hyperthermia (41.8 degrees C) combined with bimonthly oxaliplatin, high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer: a phase II study.
Hegewisch-Becker S; Gruber Y; Corovic A; Pichlmeier U; Atanackovic D; Nierhaus A; Hossfeld DK
Ann Oncol; 2002 Aug; 13(8):1197-204. PubMed ID: 12181242
[TBL] [Abstract][Full Text] [Related]
17. Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial.
Lévi FA; Zidani R; Vannetzel JM; Perpoint B; Focan C; Faggiuolo R; Chollet P; Garufi C; Itzhaki M; Dogliotti L
J Natl Cancer Inst; 1994 Nov; 86(21):1608-17. PubMed ID: 7932825
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitors may reduce the efficacy of ribociclib and palbociclib in metastatic breast cancer patients based on an observational study.
Eser K; Önder AH; Sezer E; Çil T; İnal A; Öztürk B; Erçolak V; Duman BB; Çelik H; Köşeci T; Kesen O
BMC Cancer; 2022 May; 22(1):516. PubMed ID: 35525929
[TBL] [Abstract][Full Text] [Related]
19. Combination Therapy of High-Dose Rabeprazole Plus Metronomic Capecitabine in Advanced Gastro-Intestinal Cancer: A Randomized Phase II Trial.
Roberto M; Romiti A; Mazzuca F; Milano A; D'Antonio C; Lionetto L; Falcone R; Strigari L; Simmaco M; Fais S; Marchetti P
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33105819
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the Relation between the Expression of Oxaliplatin Transporters in Colorectal Cancer and Response to FOLFOX-4 Adjuvant Chemotherapy: A Case Control Study.
Le Roy B; Tixier L; Pereira B; Sauvanet P; Buc E; Pétorin C; Déchelotte P; Pezet D; Balayssac D
PLoS One; 2016; 11(2):e0148739. PubMed ID: 26859833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
